Suven Pharmaceuticals Ltd reports consolidated PAT of Rs. 107.72 crores in Q3FY23

Suven Pharmaceuticals Limited has reported Consolidated financial results for the period ended December 31, 2022.

Financial Results (Q3 FY2023) - QoQ Comparison

The company has reported total income of Rs. 366.7829 crores during the period ended December 31, 2022 as compared to Rs. 289.3218 crores during the period ended September 30, 2022.

The company has posted net profit / (loss) of Rs. 107.7206 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 72.0563 crores for the period ended September 30, 2022.

The company has reported EPS of Rs. 4.23 for the period ended December 31, 2022 as compared to Rs. 2.83 for the period ended September 30, 2022.

Financials	Q3 FY2023	Q2 FY2023	% Change
Total Income	₹366.7829 crs	₹289.3218 crs	26.77%
Net Profit	₹107.7206 crs	₹72.0563 crs	49.50%
EPS	₹4.23	₹2.83	49.47%

Financial Results (Q3 FY2023) - YoY Comparison

The company has reported total income of Rs.366.7829 crores during the period ended December 31, 2022 as compared to Rs.456.2704 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.107.7206 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.160.0690 crores for the period ended December 31, 2021.

The company has reported EPS of Rs.4.23 for the period ended December 31, 2022 as compared to Rs.6.29 for the period ended December 31, 2021.

Financials	Q3 FY2023	Q3 FY2022	% Change
Total Income	₹366.7829 crs	₹456.2704 crs	-19.61%
Net Profit	₹107.7206 crs	₹160.0690 crs	-32.70%
EPS	₹4.23	₹6.29	-32.75%

Financial Results (9 Months Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1005.9369 crores during the 9 Months period ended December 31, 2022 as compared to Rs.1031.8840 crores during the 9 Months period ended December 31, 2021.

The company has posted net profit / (loss) of Rs.287.3190 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.362.1369 crores for the 9 Months period ended December 31, 2021.

The company has reported EPS of Rs.11.29 for the 9 Months period ended December 31, 2022 as compared to Rs.14.23 for the 9 Months period ended December 31, 2021.

Financials	9 Months Ended FY2023	9 Months Ended FY2022	% Change
Total Income	₹1005.9369 crs	₹1031.8840 crs	-2.51%
Net Profit	₹287.3190 crs	₹362.1369 crs	-20.66%
EPS	₹11.29	₹14.23	-20.66%

Shares of Suven Pharmaceuticals Limited was last trading in BSE at Rs. 484.65 as compared to the previous close of Rs. 488.20. The total number of shares traded during the day was 11829 in over 909 trades.

The stock hit an intraday high of Rs. 488.70 and intraday low of 477.75. The net turnover during the day was Rs. 5739366.00.

Source : Equity Bulls

Keywords

SuvenPharmaceuticals Q3FY23 9MFY23 ResultUpdate